Biosyent Inc (TSE:RX)
TSXV:RX
Canadian Market

Biosyent (RX) Balance Sheet

40 Followers

Biosyent Balance Sheet

Biosyent's total assets for Q4 2023 were C$41.53M, an increase of 0.32% from the previous quarter. TSE:RX total liabilities were C$6.77M for the fiscal quarter, a -1.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
C$ 41.53MC$ 40.49MC$ 37.17MC$ 33.57MC$ 30.97M
Total Liabilities
C$ 6.77MC$ 7.12MC$ 5.61MC$ 6.78MC$ 5.17M
Total Equity Gross Minority
C$ 34.76MC$ 33.36MC$ 31.55MC$ 26.80MC$ 25.79M
Total Capitalization
C$ 34.76MC$ 33.36MC$ 31.55MC$ 26.80MC$ 25.79M
Preferred Stock Equity
-----
Capital Lease Obligations
---C$ 1.71MC$ 1.85M
Currency in CAD

Biosyent Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis